In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Deals In Depth: May 2011

Executive Summary

With a three-way tie, deals by Glenmark/Sanofi, Elan/Proteostasis, and Mundipharma/Allos were each valued at $50 million. Takeda expanded into Europe and emerging markets through its $14 billion buy of Nycomed, while PE firm Cinven scored big when it sold IVD investment Phadia to Thermo Fisher Scientific for $3.5 billion. Shanghai Pharma's $1.9 billion IPO on the Hong Kong Stock Exchange pushed biopharma financing in May up to $2.8 billion. Late VC financings in the device sector made up the majority of fundraising, which totaled $469 million.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts